Introduction
Antibodies to the Rh blood group antigen Rh(D) have historically been the major cause of hemolytic disease of the fetus and newborn (HDFN). The introduction of screening for Rh(D) sensitization during pregnancy and the routine use of Rh(D) immunoglobulin have significantly reduced the incidence of HDFN.
1,2 However, maternal alloimmunization can still occur towards other minor red blood cell (RBC) antigens. 3 Clinical outcomes range from an isolated positive direct antiglobulin test (DAT) requiring no intervention to hydrops fetalis. 4, 5 In HDFN, the neonate classically presents with hyperbilirubinemia and anemia.
This case presentation reports a neonate with respiratory failure, liver dysfunction and extramedullary hematopoiesis secondary to anti-Kp a and brings attention to the potential consequences of minor blood group antigen incompatibility.
Case
The female infant was born at 35 1/7 weeks to a gravida 2 para 0-1-0-1 Filipino female. The pregnancy was complicated by hypertension, polyhydramnios and exposure to a febrile illness at 33-weeks gestation. Multiple anomalies were identified by ultrasound at 34 2/7 weeks including hepatomegaly, echogenic bowel and shortened femurs. Because of maternal hypertension, the infant was delivered preterm by cesarean section. She was admitted to the neonatal intensive care unit for respiratory failure in the delivery room.
The infant was a late preterm appropriate for gestational age female. Her physical examination was significant for a large posterior fontanelle, saddle nose deformity, poor air entry at the lung bases, grade II/VI systolic murmur, hepatosplenomegaly with a firm liver edge 9 cm below the right costal margin, a spleen tip 7 cm below the left costal margin and non-blanching palpable purpura consistent with a classic blueberry muffin rash (Figure 1 ). Admission laboratory studies revealed anemia, thrombocytopenia, coagulopathy, hyperbilirubinemia and profound hypoglycemia (Table 1 ). Maternal and neonatal evaluation for toxoplasmosis, rubella, cytomegalovirus, parvovirus and herpes simplex virus were negative. A cranial ultrasound revealed no intracranial calcifications or hemorrhage. A full sepsis evaluation for bacterial, viral and fungal pathogens in the blood, urine, cerebrospinal fluid, stool and throat was negative. Skin biopsy of the purpura was consistent with extramedullary hematopoiesis.
Because of concern for liver failure with coagulopathy and hypoglycemia on admission, the infant underwent evaluation for neonatal hemochromatosis (NH), a liver disease with extrahepatic siderosis that may present with hypoglycemia, coagulopathy and hyperbilirubinemia. 6, 7 Liver biopsy revealed extensive extramedullary hematopoiesis with abundant hemosiderin granules within hepatocytes and Kupffer cells. An abdominal MRI showed signal intensity changes in the liver suggestive of increased iron stores accompanied by equivocal signal changes in the pancreas. These findings coupled with the clinical picture were consistent with but not diagnostic for NH. A buccal biopsy was then obtained and revealed no iron deposition in the salivary glands, thereby excluding NH.
Although both the infant and her mother were blood type O positive, the DAT was 3 þ positive for IgG. Routine maternal antibody testing and the eluate of the neonate's RBCs did not identify antibody to common RBC antigens. Given the positive DAT, maternal blood was tested for antibodies to low frequency antigens, revealing the anti-Kp a antibody. The extramedullary hematopoiesis, anemia and hyperbilirubinemia were the result of chronic intrauterine hemolysis secondary to maternal anti-Kp a antibody.
This infant was hospitalized in the neonatal intensive care setting for a total of 34 days. Because of respiratory failure, she was maintained on conventional mechanical ventilation for 7 days and high-frequency oscillatory ventilation for 6 days. The infant required RBC, platelet, plasma and cryoprecipitate transfusions. Her hepatic function improved after plasma and cryoprecipitate transfusions on the first day of life. She required 10-20 ml kg À1 per day of platelets through the first week of life in order to maintain her platelet count >40 000 ml À1 . In addition, she received five RBC transfusions over the first 10 days to maintain her hemoglobin >12 g dl À1 . The infant was jaundiced at birth with a significant conjugated bilirubin fraction, which was treated with ursodiol ( Figure 2 ). Hemolysis resulting in hyperbilirubinemia was managed with intravenous immunoglobulin (IVIG). IVIG was administered in divided doses because of concerns for volume overload, and dosing was repeated as the bilirubin level approached the threshold for exchange transfusion. 8, 9 While undergoing evaluation for NH, the infant received deferoxamine for iron chelation and acetylcysteine, selenium and vitamin E for antioxidant effect. Chelation therapy was discontinued after 3 days because of concerns for infection while antioxidant therapy was discontinued after a week when the working diagnosis shifted to HDFN.
Since hospital discharge, the infant has not required a RBC transfusion. A follow-up DAT was negative. Her bilirubin has trended down on ursodiol. She consumes a low-iron formula and diet. Her ferritin has fallen from a peak of 8570 ng ml À1 at 2 weeks of age to 333 ng ml À1 at 7 months of age. Her hepatosplenomegaly persists but continues to improve with her liver 5 cm below the right costal margin and spleen 3 cm below the left costal margin at 7 months of age. Supplemental oxygen was weaned off over 3 months in the outpatient setting. She passed the Ireton Infant Development Inventory and the Denver Developmental Screening Test at her 4-and 6-month well-child visits, respectively.
Discussion
The presentation of purpura, anemia, thrombocytopenia, coagulopathy, hyperbilirubinemia and hypoglycemia in a neonate requires a broad differential including congenital infection, sepsis, Figure 1 The late preterm infant presented with prominent hepatosplenomegaly and a blueberry muffin rash. Hemolytic disease of the newborn due to anti-Kp a ischemic hepatitis, NH, inborn errors of metabolism, congenital malignancy and blood type incompatibility. An extensive evaluation was required in this case. Routine testing for an antibody causing HDFN was negative. Further testing for antibodies to rare RBC antigens resulted in the identification of anti-Kp a and confirmed the diagnosis of HDFN. The hypoglycemia and coagulopathy present on admission are not typical for a hemolytic process. They may reflect both a stress response in a critically ill infant and liver dysfunction secondary to extramedullary hematopoiesis with resultant hepatic iron deposition. In this case, chronic intrauterine hemolysis resulted in extensive extramedullary hematopoiesis in the liver, spleen and skin and respiratory failure with restrictive lung disease secondary to hepatosplenomegaly along with anemia and hyperbilirubinemia. Kp a , a Kell blood group antigen, occurs in less than 2% of Caucasians. 10 There are few case reports in the literature of HDFN due to maternal anti-Kp a alloimmunization. [11] [12] [13] [14] In contrast to previous reports of mild, self-limited disease, this neonate presented with severe transfusion-dependent HDFN due to maternal anti-Kp a alloimmunization. 15, 16 HDFN due to antibodies to uncommon red blood cell antigens should be suspected in neonates presenting with a clinical picture consistent with HDFN and a positive DAT in the absence of a positive maternal antibody screen. Further testing for antibodies to low frequency antigens, which may not have been present on cells used for the antibody screen, should be performed. In addition, compatibility testing between paternal and/or neonatal RBCs and maternal plasma may identify rare incompatibilities. Antigen typing of the neonate may further support the diagnosis of HDFN. 15 HDFN is a disease resulting from maternal alloimmunization that can occur with pregnancy, transfusion, or needle sharing. Antibody transfer to the fetus results in hemolysis and fetal anemia. Fetal erythropoiesis occurs in the bone marrow by the third trimester of pregnancy. In cases of severe hemolytic anemia, compensatory extramedullary hematopoiesis can occur. When maternal alloimmunization is suspected or known to have occurred, treatment options include IVIG, plasma exchange, intrauterine transfusion or preterm delivery. 1 Postnatal treatment of the affected neonate with HDFN focuses on supportive care for hyperbilirubinemia and anemia as occurred in this case. 4, 5 Furthermore, because the half-life of IgG is B28 days, the consequences of HDFN can be seen for up to 3 to 4 months of life and should be followed accordingly.
Conflict of interest
Drs Beck, Bendel, Brumbaugh, Kearney, Morgan and Roberts declare no conflict of interests. Dr Zantek's work has been funded in part by a research grant from Verax Biomedical, Inc., and she has received royalties from MedImmune. Hemolytic disease of the newborn due to anti-Kp a
